← All organizations
Highest phase reached
Phase 4
First clinical trial
Mar 1, 1993Last known activity
Jan 15, 2026
Timeline
1930s
- Jan 1, 1931
National Institute of Dental and Craniofacial Research (NIDCR)— Founded
Drugs by trial phase (81 distinct, 87 trials)
Phase 3 (24 own, 0 via acquisition)
Phase 2 (33 own, 0 via acquisition)
Phase 1 (12 own, 0 via acquisition)
Other trials (9 own, 0 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Acromegaly
- Acute Pain
- Back Pain
- Bacteremia
- Bone Diseases
- Burning Mouth Syndrome
- Carcinoma
- Carcinoma, Squamous Cell
- Cleft Lip
- Cleft Palate
- Dental Caries
- Diabetic Neuropathies
- DiGeorge Syndrome
- Eclampsia
- Facial Neuralgia
- Facial Pain
- Facies
- Fibrous Dysplasia of Bone
- Fibrous Dysplasia, Polyostotic
- Gingivitis
- Head and Neck Neoplasms
- HELLP Syndrome
- Herpes Zoster
- HIV Infections
- Hyperplasia
- Hypoparathyroidism
- Immunologic Deficiency Syndromes
- Inflammation
- Intractable Pain
- Joint Diseases
- Lacrimal Apparatus Diseases
- Lichen Planus
- Lichen Planus, Oral
- Malaria
- Mouth Neoplasms
- Mucositis
- Neoplasms
- Neoplasms, Connective Tissue
- Neuralgia
- Osteomalacia
- Osteoporosis
- Periodontal Diseases
- Periodontitis
- Pneumonia
- Pre-Eclampsia
- Puberty, Precocious
- Radiculopathy
- Respiratory Tract Infections
- Salivary Gland Diseases
- Sciatica
- Sepsis
- Sexually Transmitted Diseases
- Sjogren's Syndrome
- Squamous Cell Carcinoma of Head and Neck
- Stomatitis
- Syndrome
- Temporomandibular Joint Disorders
- Temporomandibular Joint Dysfunction Syndrome
- Tongue Neoplasms
- Tooth Loss
- Trigeminal Neuralgia
- Wounds and Injuries
- Xerostomia
Recent trials (50)
- NCT07281456OfficialPhase 2Jan 15, 2026
- NCT07281456Lead sponsorPhase 2Jan 15, 2026
- NCT06622213CollaboratorPhase 2Oct 15, 2024
- NCT06308913CollaboratorEarly Phase 1Sep 18, 2024
- NCT06131021CollaboratorPhase 3Apr 30, 2024
- NCT05735015Overall official - principal investigatorPhase 2Sep 22, 2023
- NCT05735015Lead sponsorPhase 2Sep 22, 2023
- NCT05554133CollaboratorN/AMar 1, 2023
- NCT05627596CollaboratorPhase 2Feb 1, 2023
- NCT05509595Lead sponsorPhase 2Dec 7, 2022
- NCT05509595Overall official - principal investigatorPhase 2Dec 7, 2022
- NCT05579639CollaboratorPhase 2Nov 30, 2022
- NCT05419050Overall official - principal investigatorPhase 2Oct 12, 2022
- NCT05419050Lead sponsorPhase 2Oct 12, 2022
- NCT04893681CollaboratorN/ADec 31, 2021
Details
- Founded
- Bethesda, MD, US Jan 1, 1931
- Last known activity
- Jan 15, 2026